Calidi Biotherapeutics (CLDI) Q2 2025 Earnings

May 14Confirmed
Q2 2024
Q3 2024
Q4 2024
Q2 2025
-2.75
-2.05
-1.35
-0.65

Details

Expected EPS
-1.8
Actual EPS
-2.16
Surprise EPS
-0.36
Surprise Percent
-20%

Description

⁨Calidi Biotherapeutics⁩ (⁦CLDI⁩) has reported earnings of ⁦-2.16⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts